about
Oral Leukoplakia as It Relates to HPV Infection: A ReviewDiagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesionsClinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adultsClinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adultsDiagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesionsOral potentially malignant disorders: is malignant transformation predictable and preventable?Qualitative analysis of the impact of Oral Potentially Malignant Disorders on daily life activities.Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patientsOral cancer development in patients with leukoplakia--clinicopathological factors affecting outcomeInterventions for treating oral leukoplakia to prevent oral cancer.Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients.High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genesPhotodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinomaMolecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatmentAetiology and risk factors for head and neck cancer: United Kingdom National Multidisciplinary Guidelines.Zyflamend reduces LTB4 formation and prevents oral carcinogenesis in a 7,12-dimethylbenz[alpha]anthracene (DMBA)-induced hamster cheek pouch model.Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia.DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.Oral cancer screening in the Bangladeshi community of Tower Hamlets: a social model.Headway and hurdles in the clinical development of dietary phytochemicals for cancer therapy and prevention: lessons learned from vitamin A derivatives.Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?Feasibility of recruitment to an oral dysplasia trial in the United KingdomA Review of Promising Natural Chemopreventive Agents for Head and Neck Cancer.Evaluation of Collagen in Leukoplakia, Oral Submucous Fibrosis and Oral Squamous Cell Carcinomas Using Polarizing Microscopy and ImmunohistochemistryExpression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma.Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions.
P2860
Q21285037-5BE2DB97-1608-4965-9AED-EC6C950394D8Q24187750-18C10313-A1EB-4C18-9715-262B589F3715Q24197586-C5A2535C-3CA5-4D5A-AC5A-B0A7FC789808Q24202313-F7BF6F33-4F5B-43AC-8AEF-E4E98201725EQ24202596-306D7857-9702-49BA-BD8B-713C65D378BAQ27003908-87D11064-E6E1-41D7-A8EA-819140B7FD21Q33565546-05F0B885-290C-44F3-8510-BD09303F755DQ33772321-E46325FB-F1FD-4785-8887-F47A11C99FCAQ34238689-BB8879B8-5359-47A6-9836-2DC5EACEE6DBQ34535749-ED633E4E-0CE3-46B0-A45A-99EB0DA61583Q34632270-0A767787-8558-476F-871F-408D2ED814B6Q36038578-32B10F09-5952-40EE-967C-D00801BA19FDQ36687568-3BDFC2A1-0901-4B66-80BE-D12D8AB6C989Q36745391-EAD4A150-9541-43D7-A63F-DC3A47257697Q36919667-7A232B7A-57BC-4ABC-B32A-8CBB4CB7337BQ36968863-827C85B1-A92E-4135-A7FC-EDC1F411166CQ37352556-4A17B81B-E5AC-4D1F-8576-0B6BD1BE108BQ37373276-A8084A6F-DE98-414E-A80C-5D591B3062AEQ37466615-1F60646E-9494-4606-A877-2417B62C3064Q37601036-EA2C61D8-885B-4814-BC2E-0B6341041A3EQ38973075-8A9DF95C-45BA-4E44-811E-E2C56DAF8104Q42326713-BEC15246-3198-4E2B-B5D3-C6BA0538E7C1Q52618019-C8A2C8FC-4EBB-41FF-A664-212489E25A89Q52716444-E89E3B62-12A6-44D5-BEC0-7C479695BC5CQ53176366-B09A5CCC-D6F4-4A25-8AED-44D286E45FA0Q55224533-6A0BD3F2-5871-4016-9F27-05B2F4898F62
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Interventions for treating oral leukoplakia
@ast
Interventions for treating oral leukoplakia
@en
Interventions for treating oral leukoplakia
@en-gb
Interventions for treating oral leukoplakia
@nl
type
label
Interventions for treating oral leukoplakia
@ast
Interventions for treating oral leukoplakia
@en
Interventions for treating oral leukoplakia
@en-gb
Interventions for treating oral leukoplakia
@nl
prefLabel
Interventions for treating oral leukoplakia
@ast
Interventions for treating oral leukoplakia
@en
Interventions for treating oral leukoplakia
@en-gb
Interventions for treating oral leukoplakia
@nl
P2093
P2860
P3181
P1476
Interventions for treating oral leukoplakia
@en
P2093
Andrea Sardella
Antonio Carrassi
Cristina Bez
Federica Demarosi
Giovanni Lodi
P2860
P3181
P356
10.1002/14651858.CD001829.PUB3
P577
2006-10-18T00:00:00Z